Literature DB >> 4023220

Intrahepatic amebic abscesses: indications for and results of percutaneous catheter drainage.

E vanSonnenberg, P R Mueller, H R Schiffman, J T Ferrucci, G Casola, J F Simeone, O A Cabrera, B B Gosink.   

Abstract

Medical therapy is standard for intrahepatic amebic abscess and generally is effective. However, we have encountered a group of patients in whom percutaneous aspiration and drainage was indicated due to uncertainty of diagnosis or clinical deterioration of the patient. Twenty such patients underwent percutaneous drainage with ultrasound or CT guidance, and each patient was cured (appropriate antibiotics were administered concomitantly). The specific indications for intervention were to differentiate pyogenic from amebic abscess, pain and imminent rupture, poor response to medical therapy, false-negative results of serologic tests, noncompliance with medical treatment, left lobe abscess, and pregnancy. Diagnosis of amebiasis from examination of the fluid was seldom possible, while findings from core biopsy of the wall of the abscess led to diagnosis in three cases. Recurrence necessitating redrainage occurred in three patients; in each, catheters were removed the same day drainage was performed. There were three minor complications. Differences from percutaneous management of pyogenic abscesses included more rapid removal of catheters (four days), more frequent use of US guidance, and more common use of the prone angled approach to avoid pleural contamination. Catheter drainage may be curative and may expedite care for problematic amebic liver abscesses in selected cases.

Entities:  

Mesh:

Year:  1985        PMID: 4023220     DOI: 10.1148/radiology.156.3.4023220

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

Review 1.  Clinical features and management of amebic liver abscess. Experience from 29 patients.

Authors:  T Weinke; W Scherer; U Neuber; M Trautmann
Journal:  Klin Wochenschr       Date:  1989-04-17

2.  Unusual multiple large abscesses of the liver: interest of the radiological features and the real-time PCR to distinguish between bacterial and amebic etiologies.

Authors:  Guillaume Desoubeaux; Hélène Chaussade; Marc Thellier; Sophie Poussing; Frédéric Bastides; Eric Bailly; Philippe Lanotte; Daniel Alison; Laurent Brunereau; Louis Bernard; Jacques Chandenier
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

3.  Appearances can be deceiving: What is the diagnosis for this community-acquired pneumonia?

Authors:  F Y Lin; C Rotstein
Journal:  Can J Infect Dis       Date:  2001-01

Review 4.  Percutaneous abscess and fluid drainage: a critical review.

Authors:  R E Lambiase
Journal:  Cardiovasc Intervent Radiol       Date:  1991 May-Jun       Impact factor: 2.740

5.  Amebic Liver Abscess.

Authors:  Wolfram Goessling; Raymond T. Chung
Journal:  Curr Treat Options Gastroenterol       Date:  2002-12

6.  A review of amoebic liver abscess for clinicians in a nonendemic setting.

Authors:  Terry Wuerz; Jennifer B Kane; Andrea K Boggild; Sigmund Krajden; Jay S Keystone; Milan Fuksa; Kevin C Kain; Ralph Warren; John Kempston; Joe Anderson
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

7.  Amoebiasis: a rare cause of cardiac tamponade.

Authors:  L N Gomersall; J Currie; R Jeffrey
Journal:  Br Heart J       Date:  1994-04

8.  Hepatic abscesses in immunocompromised patients: ultrasonically guided percutaneous drainage.

Authors:  G Civardi; C Filice; M Caremani; A Giorgio
Journal:  Gastrointest Radiol       Date:  1992

9.  Outcome of hepatic amebic abscesses managed with three different therapeutic strategies.

Authors:  C Filice; G Di Perri; M Strosselli; E Brunetti; S Dughetti; D H Van Thiel; C Scotti-Foglieni
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

10.  Amebiasis: Clinical Implications of the Recognition of Entamoeba dispar.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.